Hostname: page-component-669899f699-qzcqf Total loading time: 0 Render date: 2025-04-30T20:52:55.081Z Has data issue: false hasContentIssue false
  • English
  • Français

Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries

Published online by Cambridge University Press:  24 March 2011

John Snowdon ,
Daniel Galanos  and
Divya Vaswani
John Snowdon*
Affiliation:
Concord Hospital, Sydney, NSW, Australia
Daniel Galanos
Affiliation:
Concord Hospital, Sydney, NSW, Australia
Divya Vaswani
Affiliation:
Concord Hospital, Sydney, NSW, Australia
*
Correspondence should be addressed to: John Snowdon, Clinical Professor, Sydney Medical School, Jara Unit, Concord Hospital, NSW 2139, Australia. Phone: +61-2-97675000; Fax: + 61-2-97678951. Email: [email protected].
Get access

Abstract

Background: This study aimed to explore changes in patterns of use of psychotropic medication in Sydney nursing homes over recent years, and to compare current usage rates with those reported from other countries.

Methods: Data were obtained from 44 of the 48 nursing homes in a central Sydney health area. Researchers noted details from medication cards concerning residents’ age, gender and all currently prescribed drugs, checking whether medication had been given as prescribed. Frequency of administration of “as required” drugs in the previous four weeks was noted.

Results: The pattern of use of psychotropic medication changed considerably between 1993 and 2009. The number of residents taking regularly administered antipsychotics increased by 24% during 1998–2009, though mean dosages decreased. In 2009, fewer residents took hypnotic and/or anxiolytic medications than in the 1990s, and fewer than in countries from which equivalent data have been reported. Antidepressant use increased over the 16 years but only to 25.6%. Only 3% of residents in Sydney nursing homes in 2009 took cognition-enhancing drugs.

Conclusions: Compared to other countries, rates of use of hypnotic, anxiolytic and antidepressant medication in Sydney nursing homes are low. Benefits and disadvantages of these differences merit analysis. Antipsychotic medications were administered to similar percentages of survey residents in 1993 and 2009, but at lower mean dosages in 2009 compared to previous surveys, and with a change to using mainly atypical antipsychotic drugs. Compared to various other countries, cognition-enhancing and antidepressant medications are administered to proportionally fewer residents in Sydney nursing homes. Outcome analysis regarding the use and benefits of such drugs in nursing homes is desirable.

Keywords

antipsychoticantidepressanthypnoticanxiolyticacetylcholinesterase inhibitorsmemantineresidential caredosage
Type
Research Article
Information
International Psychogeriatrics , Volume 23 , Issue 9 , November 2011 , pp. 1520 - 1525
Copyright
Copyright © International Psychogeriatric Association 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Bains, J., Birks, J. S. and Dening, T. R. (2002). Antidepressants for treating depression in dementia. Cochrane Database Systematic Review, 4, CD003944.Google Scholar
Barca, M. L., Selbaek, G., Laks, J. and Engedal, K. (2009). Factors associated with depression in Norwegian nursing homes. International Journal of Geriatric Psychiatry, 24, 417–425.CrossRefGoogle ScholarPubMed
Bharucha, A. J., Dew, M. A., Miller, M. D., Borson, S. and Reynolds, C. (2006). Psychotherapy in long-term care: a review. Journal of the American Medical Directors Association, 7, 568–580.CrossRefGoogle ScholarPubMed
Brodaty, H. et al. (2003). A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation and psychosis of dementia. Journal of Clinical Psychiatry, 64, 134–143.CrossRefGoogle ScholarPubMed
Hosia-Randell, H. and Pitkälä, , , K. (2005). Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs and Aging, 22, 793–800.CrossRefGoogle ScholarPubMed
Hughes, C. M. et al. (2000). The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. Journal of the American Geriatrics Society, 48, 931–937.CrossRefGoogle ScholarPubMed
Kim, H. and Whall, A. L. (2006). Factors associated with psychotropic drug usage among nursing home residents with dementia. Nursing Research, 55, 252–258.CrossRefGoogle ScholarPubMed
Lövheim, H., Sandman, P. O., Kallin, K., Karlsson, S. and Gustafson, Y. (2006). Relationship between antipsychotic drug use and behavioural and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care. International Psychogeriatrics, 18, 713–726.CrossRefGoogle ScholarPubMed
Nijk, R. M., Zuidema, S. U. and Koopmans, R. T. C. M. (2009). Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. International Psychogeriatrics, 21, 485–493.CrossRefGoogle ScholarPubMed
Nishtala, P. S., McLachlan, A. J., Bell, J. S. and Chen, T. F. (2010). Determinants of antipsychotic medication use among older people living in aged care homes in Australia. International Journal of Geriatric Psychiatry, 25, 449–457.CrossRefGoogle ScholarPubMed
Patterson, S. M., Hughes, C. M., Crealey, G., Cardwell, C. and Lapane, K. L. (2010). An evaluation of an adapted US model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study). Journal of the American Geriatrics Society, 58, 44–53.CrossRefGoogle ScholarPubMed
Seitz, D. P., Gruneir, A., Conn, D. K. and Rochon, P. A. (2009). Cholinesterase inhibitor use in U.S. nursing homes: results from the national nursing home survey. Journal of the American Geriatrics Society, 57, 2269–2274.CrossRefGoogle ScholarPubMed
Selbaek, G., Kirkevold, Ø. and Engedal, K. (2007). The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. International Journal of Geriatric Psychiatry, 22, 843–849.CrossRefGoogle ScholarPubMed
Snowdon, J. (1999). A follow-up survey of psychotropic drug use in Sydney nursing homes. Medical Journal of Australia, 170, 299–301.CrossRefGoogle ScholarPubMed
Snowdon, J., Vaughan, R., Miller, R., Burgess, E. E. and Tremlett, P. (1995). Psychotropic drug use in Sydney nursing homes. Medical Journal of Australia, 163, 70–72.CrossRefGoogle ScholarPubMed
Snowdon, J., Day, S. and Baker, W. (2006). Current use of psychotropic medication in nursing homes. International Psychogeriatrics, 18, 241–250.CrossRefGoogle ScholarPubMed
Stevenson, D. G. et al. (2010). Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. American Journal of Geriatric Psychiatry, 18, 1078–1092.CrossRefGoogle ScholarPubMed
Tucker, M. and Hosford, I. (2008). Use of psychotropic medicines in residential care facilities for older people in Hawke's Bay, New Zealand. New Zealand Medical Journal, 121, 18–25.Google ScholarPubMed
Westbury, J., Jackson, S., Gee, P. and Peterson, G. (2010). An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. International Psychogeriatrics, 22, 26–36.CrossRefGoogle ScholarPubMed
Weyerer, S., Schäufele, M. and Hendlmeier, I. (2010). Evaluation of special and traditional dementia care in nursing homes: results from a cross-sectional study in Germany. International Journal of Geriatric Psychiatry, 25, 1159–1167.CrossRefGoogle ScholarPubMed